Jing Yan

Title: Jing Yan - Innovator in Cancer Treatment

Introduction

Jing Yan is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative pharmaceutical compositions. With a total of 2 patents, his work focuses on utilizing cyclometalated N-heterocyclic carbene complexes for therapeutic purposes.

Latest Patents

Jing Yan's latest patents include a pharmaceutical composition that contains cyclometalated N-heterocyclic carbene complexes specifically designed for cancer treatment. This composition features a cyclometalated N-heterocyclic carbene complex that incorporates either a gold(III) or a platinum(II) atom. The pharmaceutical composition exhibits notable anti-cancer activity, which includes the induction of cell death, inhibition of cellular proliferation, and the inhibition and poisoning of topoisomerase.

Career Highlights

Jing Yan is affiliated with The University of Hong Kong, where he conducts research and develops innovative solutions for cancer treatment. His work has garnered attention for its potential impact on improving therapeutic outcomes for cancer patients.

Collaborations

Jing Yan collaborates with esteemed colleagues such as Chi Ming Che and Raymond Wai-Yin Sun. Their combined expertise contributes to the advancement of research in the field of cancer treatment.

Conclusion

Jing Yan is a dedicated inventor whose work in pharmaceutical compositions for cancer treatment showcases his commitment to innovation and improving patient care. His contributions are paving the way for new therapeutic approaches in oncology.